ACS

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

By

Investigators examined whether influenza is an independent risk factor for the development of acute myocardial infarction.

Risk for Acute Myocardial Infarction Increased in Multiple Sclerosis

Risk for Acute Myocardial Infarction Increased in Multiple Sclerosis

By

Evidence suggests a possible role for inflammation in the association between MS and myocardial infarction risk.

Lixisenatide Reduces Macroalbuminuria Risk in ACS With T2DM

Lixisenatide Reduces Macroalbuminuria Risk in ACS With T2DM

Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria

Clinical Challenge: Young Woman With Arm Numbness and Shortness of Breath

Clinical Challenge: Young Woman With Arm Numbness and Shortness of Breath

A young patient presents with an increased heart rate that skipped a beat, shortness of breath, and tingling and numbness down her right arm.

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

By

An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.

Early vs Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

Early vs Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

By

In patients with non-ST-elevation acute coronary syndromes, an early invasive treatment strategy does not significantly reduce mortality rates.

Herpes Zoster May Increase Risk of Myocardial Infarction, Stroke

Herpes Zoster May Increase Risk of Myocardial Infarction, Stroke

Herpes zoster may be linked to increased cardiovascular events risk.

Acute Myocardial Infarction Risk May Increase With Use of NSAIDs

Acute Myocardial Infarction Risk May Increase With Use of NSAIDs

NSAIDs increase myocardial infarction risk by 20% to 50%.

Chronic Angina Therapy Gets Fast Track Designation From FDA

Chronic Angina Therapy Gets Fast Track Designation From FDA

By

XyloCor's XC001 is a potential therapy for patients with chronic angina.

Sign Up for Free e-Newsletters